[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
D001984:Bronchial Neoplasms / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002455:Cell Division; D002822:Choriocarcinoma / Q000188:drug therapy; D005047:Etoposide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011247:Pregnancy; D013736:Testicular Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D005047:Etoposide; D011034:Podophyllotoxin
Etoposid. Ein neues Zytostatikum mit hoher Wirksamkeit beim anaplastischen kleinzelligen Bronchuskarzinom, bei anderen soliden Tumoren und bei Hämoblastosen.